|
|
|
|
|
|
|
|
|
|
"Altogether, our data show that 6TG efficiently kills BRCA2-defective tumors and suggest that 6TG may be effective in the treatment of advanced tumors that have developed resistance to PARP inhibitors or platinum-based chemotherapy. Cancer Res; 70(15); OF1-9. (c)2010 AACR."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.